Atlas Trials

A Study of LCZ696 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers

Clinical trial NCT01621633 · COMPLETED

Trial details

NCT number
NCT01621633
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2012-09-01
Primary completion
2013-01-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.